Concepedia

Efi Gymnopoulou

EG

Statistics

Publications

6

Citations

309

H-Index

6

Active since

2019

Affiliations

Janssen (Belgium)(Current)

Janssen (Netherlands)

Janssen (United States)

University of Tennessee Health Science Center

University of Rochester

Efi Gymnopoulou is an author at Janssen (Belgium) specializing in infectious diseases, veterinary medicine, and vaccination.

Publications per year

2019–2023

6

Publications

6

Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults

Ann R. Falsey, Kristi L. Williams, Efi Gymnopoulou et al. · New England Journal of Medicine · 2023 · 146 citations · Full text

, , +17

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study

Jerald Sadoff, Els De Paepe, John P. DeVincenzo et al. · The Journal of Infectious Diseases · 2021 · 90 citations · Full text

, , +17

Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months

Arabella Stuart, Miia Virta, Kristi L. Williams et al. · The Journal of Infectious Diseases · 2022 · 37 citations · Full text

, , +17

LB14. Efficacy and Immunogenicity of an Ad26.RSV.preF-based Vaccine in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged ≥65 Years: A Randomized, Placebo-controlled, Phase 2b Study

Ann R. Falsey, Kristi L. Williams, Efi Gymnopoulou et al. · Open Forum Infectious Diseases · 2021 · 14 citations · Full text

, , +17

Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire™ symptom scores

Richard H. Osborne, Lauren Nelson, Sheri Fehnel et al. · Journal of Patient-Reported Outcomes · 2023 · 12 citations · Full text

, , +16

1–5 of 6